Clinical Trial Update: Interventional Study to Improve Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia [NA]

View source ↗

Summary

Interventional study aiming to improve adherence to tyrosine kinase inhibitors in patients with chronic myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Tyrosine kinase inhibitors (class) (tyrosine kinase inhibitor)

Snippet

Sponsor: pia raanani | Conditions: Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Medication Adherence | NA | Status: COMPLETED